LONDON, August 5, 2011 /PRNewswire/ --
Medical devices group Smith & Nephew reports sales growth of 12% and underlying sales growth of 5%.
In an interview with financial broadcaster http://www.cantos.com, new CEO Olivier Bohuon talks Q2 results and introduces his plans for a new Strategic Framework that details efficiency plans and announces a new focus on emerging markets.
Bohuon also announced plans to inject an additional $300m into R&D over the next five years, and to focus the business on performance, innovation and a more global presence.
The interview and transcript are available now on http://www.cantos.com/company/Smith%20and%20Nephew
Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email email@example.com or phone +44-207-936-1352.
SOURCE Smith & Nephew plc